Inside the research
Fidelity National Financial, Inc.
FNF Research profile · latest available data
Price overview
$41.42
▲ +0.60 (+1.5%)
| 52w hi | $55.86 |
|---|---|
| 52w lo | $40.82 |
| Vol | 2.75M |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.21
| Short | -0.31 |
|---|---|
| Medium | -0.22 |
| Long | +0.03 |
computed 2026-09-27
Key fundamentals
Fidelity National Financial, Inc.
Financial Services · Insurance - Specialty
| Market cap | $11.11B |
|---|---|
| Enterprise value | $13.23B |
| Trailing P/E | 14.43x |
| Forward P/E | 7.16x |
| EV / EBITDA | 5.49x |
| P / S (ttm) | 0.72x |
| Profit margin | 5.0% |
| Return on equity | 10.2% |
| Revenue growth | +10.5% |
| Earnings growth | +5.8% |
| Debt / equity | 54.30 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.26 | |
| Sector | +0.02 | |
| Technical | -0.27 | |
| Earnings | +0.00 | |
| Sentiment | +0.04 |
macro × 1.00 · 2026-09-27
Business overview
Fidelity National Financial, Inc., together with its subsidiaries, provides various insurance products in the United States. It operates through Title, F&G, and Corporate and Other segments. The company offers title insurance, escrow, and other title related services, including trust activities, trustee sales guarantees, recordings and reconveyances, and home warranty products. It also provides technology and transaction services to the real estate and mortgage industries; and mortgage transaction services, including title-related services and facilitation of production and management of mortgage loans. In addition, the company offers annuity and life insurance products, such as deferred and immediate annuities, as well as indexed universal life insurance products; and funding agreements and pension risk transfer (PRT) solutions. Further, it engages in the real estate brokerage business. Fidelity National Financial, Inc. was incorporated in 2005 and is headquartered in Jacksonville, Florida.
Risk Metrics
| Beta vs SPX | 0.55 |
|---|---|
| Corr SPX | 0.34 |
| Annual vol | 26.5% |
| Annual ret | -14.0% |
| Sharpe | -0.53 |
| Max DD | -36.4% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $64.25 |
|---|---|
| High / Low | $70.00 / $54.00 |
| Median | $66.50 |
| Analysts | 4 |
| Strong Buy | 1 | |
|---|---|---|
| Buy | 3 | |
| Hold | 1 | |
| Sell | 0 | |
| Strong Sell | 0 |
Recent rating actions
| 2026-04-10 | Keefe, Bruyette & Woods | → Outperform |
| 2026-04-06 | Barclays | → Equal-Weight |
| 2026-02-23 | Keefe, Bruyette & Woods | → Outperform |
| 2026-01-06 | Barclays | → Equal-Weight |
| 2025-12-18 | Keefe, Bruyette & Woods | → Outperform |
| 2025-11-10 | Keefe, Bruyette & Woods | → Outperform |
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-05 | Earnings Release, Exhibits | read |
| 2026-06-11 | Bylaws Amendment, Shareholder Vote… | read |
| 2026-05-12 | Officer / Director Change, Exhibits | read |
| 2026-05-06 | Earnings Release, Exhibits | read |
| 2026-02-19 | Earnings Release, Exhibits | read |
| 2025-12-18 | Other Material Event, Exhibits | read |
| 2025-11-07 | Other Material Event, Exhibits | read |
| 2025-11-06 | Earnings Release, Exhibits | read |
| 2025-08-06 | Earnings Release, Exhibits | read |
| 2025-06-12 | 3.03, Bylaws Amendment… | read |
| 2025-06-04 | Material Agreement, Other Material Event… | read |
| 2025-05-07 | Earnings Release, Exhibits | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-26 | SADOWSKI PETER T | EVP, Chief Legal Officer | Sell | 69.20K | $3.16M |
| 2026-06-24 | Dhanidina Halim | Sell | 9.54K | $3.99M | |
| 2026-05-08 | Nolan Michael Joseph | Chief Executive Officer | Grant | 39.54K | — |
| 2026-04-08 | SADOWSKI PETER T | EVP, Chief Legal Officer | Sell | 473 | $22.55K |
| 2026-01-05 | Dhanidina Halim | Sell | 6.00K | $335.40K |
Flow & Concentration
| Insider 180d net | -$7.18M |
|---|---|
| Insider buys / sells | 0 / 3 |
| Insider bias | Sellers |
| 13F holders | 0 |
| Top-5 share | 0.0% |
| HHI | 0 (—) |
Dividends
| Yield (TTM) | 2.51% |
|---|---|
| $ / share (TTM) | $1.04 |
| 5y CAGR | +9.5% |
Annual dividend per share
| 2021 | $1.45 |
|---|---|
| 2022 | $1.66 |
| 2023 | $1.76 |
| 2024 | $1.87 |
| 2025 | $1.97 |
| 2026 | $0.52 |
SEC Filings
The Long Run
FY 2010–2025 · 16 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $2.10B | -6.5% | |
| Net income | $517.00M | +2.4% | |
| Cash from ops | $6.82B | +21.2% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $40.88 | $41.52 | $40.81 | $41.42 | 2.75M |
| Sep 24 | $41.91 | $42.17 | $40.81 | $40.82 | 3.49M |
| Sep 23 | $42.24 | $42.87 | $41.82 | $41.85 | 1.97M |
| Sep 22 | $42.67 | $42.87 | $42.05 | $42.55 | 2.68M |
| Sep 21 | $42.86 | $43.24 | $42.43 | $42.46 | 2.24M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →